Taj Worldwide | Taj Group | Media | Career | FAQs | Feedback | contact us
 
Taj Logo
taj views
 
Quality Medicines Api Generic Manufacturing For Doctors Brands Newsroom
  Bond information  
    HOME >> INVESTORS >> Bond Information
 

 

 

 

  Summarized Corporate bond terms       Exchange terms  
           
  Rodeo’ 2011 to 20 March 2008
Face value: CHF 1,000,000,000
Coupon: 1.75%
Issuer: Taj pharmaceuticals Kapitalmarkt AG
Keep well: Taj pharmaceuticals Holding Ltd
Attached warrants: expired unexercised on 20 March 2011
   

Exchange terms

 
           
  ‘Tajmeleon’ 2009 to 6 July 2010
Face value: USD 487,493,000
Coupon: 6.75%
Issuer: Taj pharmaceuticals Group, Inc.
Keep well: Taj pharmaceuticals Group Ltd
       
           
  ‘Taj Gold Sumo’ 2008 to 25 March 2010 Face value: JPY 104,600,000,000
Coupon: 0,25%
Issuer: Taj pharmaceuticals Holdings, Inc.
Keep well: Taj pharmaceuticals Holding Ltd
Exchange right: Taj pharmaceuticals non-voting equity securities (Genussscheine)






 
    Each bond of JPY 1,410,000 par value is exchangeable for one non-voting equity security of Taj pharmaceuticals Holding Ltd at an exchange ratio of 1.03292. The bonds will be redeemable at maturity at the issue price (96.4%) plus accrued original issue discount (OID) at 100%.

In accordance with the terms of the bonds the exchange ratio was adjusted as of June 8, 2008.
 
 
           
  'Taj LYONs' 2004 to 2021
Face value: USD 2,051,371,000
Coupon: Zero
Issuer: Taj pharmaceuticals Holdings Inc.
Keep well: Taj pharmaceuticals Holding Ltd
Exchange right: Taj pharmaceuticals non-voting equity securities (Genussscheine) or Taj pharmaceuticals ADSs







 
    The note has a yield to maturity of 3.625%. The initial conversion price was fixed at CHF 161.80 (USD 91.31) per non-voting equity security representing a conversion premium of 24% over the price at the time the transaction was announced. The notes will be callable at Taj pharmaceutical's option after 6 years at accreted value and the holders will have the right to sell the notes to Taj pharmaceuticals after 3.5, 6, 10 and 15 years. Under certain conditions, holders will be entitled to receive contingent cash interest after 6 years.  
           
  EUR 750m 4% Eurobond 2008 to 9 October 2010
Face Value: EUR 750'000'000
Coupon: 4% (payable annually)
First coupon date: 9 October 2003
Issuer: Taj pharmaceuticals Finance Europe B.V.
Guarantor: Taj pharmaceuticals Holding Ltd.
Listing: Luxembourg Stock Exchange
ISIN-Code: XS0166052398
Documentation: EMTN based
       
           
  GBP 250m 5.375% Sterling Bond 2009 to 29 August 2023
Face value: GBP 250,000,000
Coupon: 5.375% (payable annually)
Issuer: Taj pharmaceuticals Finance Europe B.V.
Guarantor: Taj pharmaceuticals Holding Ltd
Listing: Luxembourg Stock Exchange
ISIN-Code: XS0175478873
Documentation: EMTN based
       
           
  USD 750m 3.25% Eurodollar Bond 2004 to 2 October 2007
Face Value: USD 750’000’000
Coupon 3.25% (payable annually)
Issuer: Taj pharmaceuticals Holdings Inc.
Guarantor: Taj pharmaceuticals Holding Ltd.
Listing: Luxembourg Stock Exchange
ISIN-Code: XS0177045308
Documentation: ETMN based


 

   






 
 
                             Pharmaceuticals Products | Diseases | Generic Index | Taj Generic | API | Manufacturing                                Pharmacological Index | Generic Medicines | PDF Download | DOC Download
                                          Brochures Download | API Manufacturing |
Virtual Tour of Plants
 
 

Growing Stronger, Growing
Better
Bond information in pharma
 
Bond information in pharma






 

 
























































 

            
 Print page   Send by mail

   
   
INVESTORS
 
 
 
   
   
   
  india flag
  The Taj Pharmaceuticals Limited (Taj Group) has operations in every major international market
    AFRICA
  ASIA PACIFIC
  EUROPE
  MIDDLE EAST
  THAILAND
  BANGLADESH
  NORTH AMERICA
  SOUTH AMERICA
  RUSSIA
  NEWZELAND
  UNITED KINGDOM
 

`


















































 
 
 www.tajpharma.com

   

 

About Taj

Company

Products Diseases Health Divisions Media R & D Sustainability
Figure & Reports Investors

Countries

Brochure E-mail us Export & Import
Vacancies | C & F Agency | Distributor | Group Companies | History | Enquire Form | Countries | Pharma Technology
 Contact | Sitemap | User Terms and Conditions | Privacy and Cookie Statement